Compton Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,340
| Closed | -$555K | – | 156 |
|
|
2022
Q1 | $555K | Sell |
4,340
-408
| -9% | -$49.2K | 0.16% | 107 |
|
|
2021
Q4 | $586K | Buy |
4,748
+1,390
| +41% | +$182K | 0.15% | 108 |
|
|
2021
Q3 | $477K | Hold |
3,358
| – | – | 0.14% | 113 |
|
|
2021
Q2 | $524K | Sell |
3,358
-51
| -1% | -$8.26K | 0.15% | 105 |
|
|
2021
Q1 | $530K | Hold |
3,409
| – | – | 0.17% | 103 |
|
|
2020
Q4 | $510K | Hold |
3,409
| – | – | 0.17% | 91 |
|
|
2020
Q3 | $451K | Hold |
3,409
| – | – | 0.17% | 89 |
|
|
2020
Q2 | $395K | Buy |
3,409
+515
| +18% | +$59.3K | 0.17% | 91 |
|
|
2020
Q1 | $284K | Hold |
2,894
| – | – | 0.14% | 104 |
|
|
2019
Q4 | $421K | Hold |
2,894
| – | – | 0.16% | 96 |
|
|
2019
Q3 | $386K | Sell |
2,894
-155
| -5% | -$20K | 0.16% | 101 |
|
|
2019
Q2 | $349K | Sell |
3,049
-103
| -3% | -$12.1K | 0.15% | 105 |
|
|
2019
Q1 | $391K | Hold |
3,152
| – | – | 0.17% | 104 |
|
|
2018
Q4 | $317K | Hold |
3,152
| – | – | 0.15% | 111 |
|
|
2018
Q3 | $402K | Hold |
3,152
| – | – | 0.16% | 111 |
|
|
2018
Q2 | $341K | Hold |
3,152
| – | – | 0.14% | 118 |
|
|
2018
Q1 | $334K | Hold |
3,152
| – | – | 0.14% | 120 |
|
|
2017
Q4 | $369K | Buy |
3,152
+129
| +4% | +$14.6K | 0.16% | 113 |
|
|
2017
Q3 | $344K | Sell |
3,023
-286
| -9% | -$33K | 0.15% | 115 |
|
|
2017
Q2 | $413K | Hold |
3,309
| – | – | 0.19% | 104 |
|
|
2017
Q1 | $392K | Buy |
3,309
+80
| +2% | +$9.07K | 0.19% | 101 |
|
|
2016
Q4 | $324K | Sell |
3,229
-3,229
| -50% | -$346K | 0.17% | 106 |
|
|
2016
Q3 | $785K | Buy |
6,458
+3,229
| +100% | +$399K | 0.22% | 94 |
|
|
2016
Q2 | $377K | Buy |
3,229
+77
| +2% | +$8.71K | 0.21% | 101 |
|
|
2016
Q1 | $326K | Hold |
3,152
| – | – | 0.18% | 100 |
|
|
2015
Q4 | $314K | Buy |
3,152
+309
| +11% | +$30.2K | 0.18% | 103 |
|
|
2015
Q3 | $259K | Sell |
2,843
-492
| -15% | -$49.3K | 0.09% | 115 |
|
|
2015
Q2 | $354K | Hold |
3,335
| – | – | 0.19% | 101 |
|
|
2015
Q1 | $381K | Hold |
3,335
| – | – | 0.21% | 99 |
|
|
2014
Q4 | $367K | Sell |
3,335
-721
| -18% | -$76K | 0.2% | 103 |
|
|
2014
Q3 | $396K | Sell |
4,056
-151
| -4% | -$14.9K | 0.22% | 100 |
|
|
2014
Q2 | $424K | Hold |
4,207
| – | – | 0.23% | 94 |
|
|
2014
Q1 | $386K | Hold |
4,207
| – | – | 0.22% | 96 |
|
|
2013
Q4 | $381K | Hold |
4,207
| – | – | 0.22% | 98 |
|
|
2013
Q3 | $335K | Hold |
4,207
| – | – | 0.2% | 104 |
|
|
2013
Q2 | $306K | Buy |
+4,207
| New | +$315K | 0.19% | 106 |
|
Other funds holding ZBH
Compton Capital Management's ZBH Position: Q2 2022 in Review
Compton Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 4,340 shares — an estimated $555K sold.
Compton Capital Management first reported a position in ZBH in Q2 2013 and held it in 36 quarters. The position peaked at $785K in Q3 2016. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.
- Compton Capital Management reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
- Compton Capital Management sold 4,340 Zimmer Biomet shares in Q2 2022, an estimated $555K.
- Compton Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 36 quarters.
- Compton Capital Management's Zimmer Biomet position peaked at $785K in Q3 2016.
- 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.
Based on Compton Capital Management's 13F filing for Q2 2022, filed 4 Aug 2022.